Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection

BMC Immunology

Volumn 11, Issue , 2010, Pages

  de Oliveira Fraga, Lucia A ^a,b   Lamb, Erika W ^a,e   Moreno, Elizabeth C ^c   Chatterjee, Mitali ^a   Dvořák, Jan ^d   Delcroix, Melaine ^d,f   Sajid, Mohammed ^d,g   Caffrey, Conor R ^d   Davies, Stephen J ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSIDADE VALE DO RIO DOCE   (Brazil)

^c FUNDAÇÃO NACIONAL DE SAÚDE   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f Afd Parasitologie ^*  (United States)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN E; INTERLEUKIN 4; SMCB1 ENZYME; UNCLASSIFIED DRUG; CATHEPSIN B; CB2 PROTEIN, SCHISTOSOMA MANSONI; HELMINTH PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; SCHISTOSOMIASIS; TH2 CELL; ADAPTIVE IMMUNITY; ANIMAL; BLOOD; GENETICS; IMMUNOLOGY; LIFE CYCLE; METABOLISM; PATHOGENICITY; SCHISTOSOMA MANSONI; TH1 TH2 BALANCE;

ADAPTIVE IMMUNITY; ANIMALS; CATHEPSIN B; FEMALE; HELMINTH PROTEINS; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-4; LIFE CYCLE STAGES; MALE; MICE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TH1-TH2 BALANCE; TH2 CELLS;

EID: 78149418680     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-56     Document Type: Article

References (63)

1. Pearce EJ, Sher A. Mechanisms of immune evasion in schistosomiasis. Contrib Microbiol Immunol 1987, 8:219-232.
2. McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008, 21:225-242. 10.1128/CMR.00046-07, 2223839, 18202444.
3. Hewitson JP, Hamblin PA, Mountford AP. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol 2005, 27:271-280. 10.1111/j.1365-3024.2005.00764.x, 16138848.
4. Davies SJ, Grogan JL, Blank RB, Lim KC, Locksley RM, McKerrow JH. Modulation of Blood Fluke Development in the Liver by Hepatic CD4+ Lymphocytes. Science 2001, 294:1358-1361. 10.1126/science.1064462, 11701932.
5. Harrison RA, Doenhoff MJ. Retarded development of Schistosoma mansoni in immunosuppressed mice. Parasitology 1983, 86:429-438. 10.1017/S0031182000050629, 6877869.
6. Pearce EJ. Priming of the immune response by schistosome eggs. Parasite Immunol 2005, 27:265-270. 10.1111/j.1365-3024.2005.00765.x, 16138847.
7. Grzych JM, Pearce E, Cheever A, Caulada ZA, Caspar P, Heiny S, Lewis F, Sher A. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol 1991, 146:1322-1327.
8. Stadecker MJ, Hernandez HJ, Asahi H. The identification and characterization of new immunogenic egg components: implications for evaluation and control of the immunopathogenic T cell response in schistosomiasis. Mem Inst Oswaldo Cruz 2001, 96(Suppl):29-33.
9. Chen Y, Boros DL. Identification of the immunodominant T cell epitope of p38, a major egg antigen, and characterization of the epitope-specific Th responsiveness during murine schistosomiasis mansoni. J Immunol 1998, 160:5420-5427.
10. Hernandez HJ, Edson CM, Harn DA, Ianelli CJ, Stadecker MJ. Schistosoma mansoni: genetic restriction and cytokine profile of the CD4 + T helper cell response to dominant epitope peptide of major egg antigen Sm-p40. Exp Parasitol 1998, 90:122-130. 10.1006/expr.1998.4309, 9709038.
11. Everts B, Perona-Wright G, Smits HH, Hokke CH, van der Ham AJ, Fitzsimmons CM, Doenhoff MJ, van der Bosch J, Mohrs K, Haas H, et al. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J Exp Med 2009, 206:1673-1680. 10.1084/jem.20082460, 2722183, 19635864.
12. Steinfelder S, Andersen JF, Cannons JL, Feng CG, Joshi M, Dwyer D, Caspar P, Schwartzberg PL, Sher A, Jankovic D. The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J Exp Med 2009, 206:1681-1690. 10.1084/jem.20082462, 2722182, 19635859.
13. Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 1991, 173:159-166. 10.1084/jem.173.1.159, 2118762, 1824635.
14. de Oliveira Fraga LA, Torrero MN, Tocheva AS, Mitre E, Davies SJ. Induction of type 2 responses by schistosome worms during prepatent infection. J Infect Dis 2010, 201:464-472. 10.1086/649841, 2842083, 20043751.
15. Balloul JM, Sondermeyer P, Dreyer D, Capron M, Grzych JM, Pierce RJ, Carvallo D, Lecocq JP, Capron A. Molecular cloning of a protective antigen of schistosomes. Nature 1987, 326:149-153. 10.1038/326149a0, 2434863.
16. Pearce EJ, James SL, Dalton J, Barrall A, Ramos C, Strand M, Sher A. Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Immunol 1986, 137:3593-3600.
17. Strand M, Dalton JP, Tom TD. Characterization and cloning of Schistosoma mansoni immunogens recognized by protective antibodies. Acta Trop Suppl 1987, 12:75-82.
18. Correa-Oliveira R, Pearce EJ, Oliveira GC, Golgher DB, Katz N, Bahia LG, Carvalho OS, Gazzinelli G, Sher A. The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans R Soc Trop Med Hyg 1989, 83:798-804. 10.1016/0035-9203(89)90334-9, 2617649.
19. El Ridi R, Farouk F, Sherif M, Al-Sherbiny M, Osman A, El Gengehi N, Shoemaker CB. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium. J Infect Dis 1998, 177:1364-1372. 10.1086/515274, 9593026.
20. Goudot-Crozel V, Caillol D, Djabali M, Dessein AJ. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase. J Exp Med 1989, 170:2065-2080. 10.1084/jem.170.6.2065, 2189537, 2584935.
21. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994, 1:327-339. 10.1016/1074-7613(94)90084-1, 7889419.
22. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994, 1:167-178. 10.1016/1074-7613(94)90095-7, 7534202.
23. Caffrey CR, McKerrow JH, Salter JP, Sajid M. Blood 'n' guts: an update on schistosome digestive peptidases. Trends Parasitol 2004, 20:241-248. 10.1016/j.pt.2004.03.004, 15105025.
24. Chappell CL, Hackel J, Davis AH. Cloned Schistosoma mansoni proteinase (hemoglobinase) as a putative serodiagnostic reagent. J Clin Microbiol 1989, 27:196-198. 267263, 2492298.
25. Grogan J, Rotmans P, Ghoneim H, Deelder A, Yazdanbakhsh M, Klinkert MQ. Recognition of Schistosoma mansoni cathepsins B and L by human IgG1 and IgG4 antibodies. Parasite Immunol 1997, 19:215-220. 10.1046/j.1365-3024.1997.d01-199.x, 9194098.
26. Klinkert MQ, Bommert K, Moser D, Felleisen R, Link G, Doumbo O, Beck E. Immunological analysis of cloned Schistosoma mansoni antigens Sm31 and Sm32 with sera of schistosomiasis patients. Trop Med Parasitol 1991, 42:319-324.
27. Chappell CL, Dresden MH. Antibody response to a purified parasite proteinase (SMw32) in Schistosoma mansoni infected mice. Am J Trop Med Hyg 1988, 39:66-73.
28. Vercelli D, Jabara HH, Arai K, Geha RS. Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J Exp Med 1989, 169:1295-1307. 10.1084/jem.169.4.1295, 2189234, 2522501.
29. LoVerde PT, Chen L. Schistosome female reproductive development. Parasitology Today 1991, 7:303-307. 10.1016/0169-4758(91)90263-N, 15463396.
30. McCoy KD, Harris NL, Diener P, Hatak S, Odermatt B, Hangartner L, Senn BM, Marsland BJ, Geuking MB, Hengartner H, et al. Natural IgE production in the absence of MHC Class II cognate help. Immunity 2006, 24:329-339. 10.1016/j.immuni.2006.01.013, 16546101.
31. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991, 349:243-245. 10.1038/349243a0, 1898985.
32. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC, Mashiyama ST, Al-Lazikani B, Andrade LF, Ashton PD, et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009, 460:352-358. 10.1038/nature08160, 2756445, 19606141.
33. Jolly ER, Chin CS, Miller S, Bahgat MM, Lim KC, DeRisi J, McKerrow JH. Gene expression patterns during adaptation of a helminth parasite to different environmental niches. Genome Biol 2007, 8:R65. 10.1186/gb-2007-8-4-r65, 1896014, 17456242.
34. Mikhail MM, Mansour MM, Farid Z, Harrison R. Schistosoma mansoni antigens applicable to diagnosis of prepatent infections. J Egypt Soc Parasitol 1997, 27:1-20.
35. Klinkert MQ, Felleisen R, Link G, Ruppel A, Beck E. Primary structures of Sm31/32 diagnostic proteins of Schistosoma mansoni and their identification as proteases. Mol Biochem Parasitol 1989, 33:113-122. 10.1016/0166-6851(89)90025-X, 2725581.
36. Skelly PJ, Shoemaker CB. Schistosoma mansoni proteases Sm31 (cathepsin B) and Sm32 (legumain) are expressed in the cecum and protonephridia of cercariae. J Parasitol 2001, 87:1218-1221.
37. Štefanić S, Dvořák J, Horn M, Braschi S, Sojka D, Ruelas D, Suzuki B, Lim KC, Hopkins SD, McKerrow JH, Caffrey CR. RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. PLoS Negl Trop Dis 2010,
38. Correnti JM, Brindley PJ, Pearce EJ. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol 2005, 143:209-215. 10.1016/j.molbiopara.2005.06.007, 16076506.
39. Abdulla MH, Lim KC, Sajid M, McKerrow JH, Caffrey CR. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med 2007, 4:e14. 10.1371/journal.pmed.0040014, 1764436, 17214506.
40. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435. 10.1038/nature07201, 18650913.
41. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008, 9:310-318. 10.1038/ni1558, 18300366.
42. Lecaille F, Kaleta J, Bromme D. Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev 2002, 102:4459-4488. 10.1021/cr0101656, 12475197.
43. McKerrow JH. Cysteine proteases of parasites: A remarkable diversity of function. Perspectives in Drug Discovery and Design 1994, 2:437-444.
44. McMichael AJ, Phillips RE. Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 1997, 15:271-296. 10.1146/annurev.immunol.15.1.271, 9143689.
45. Suzuki Y. Natural selection on the influenza virus genome. Mol Biol Evol 2006, 23:1902-1911. 10.1093/molbev/msl050, 16818477.
46. Cooreman MP, Leroux-Roels G, Paulij WP. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001, 8:237-247. 10.1007/BF02256597, 11385295.
47. Sternberg JM. Human African trypanosomiasis: clinical presentation and immune response. Parasite Immunol 2004, 26:469-476. 10.1111/j.0141-9838.2004.00731.x, 15771682.
48. Martin DL, Weatherly DB, Laucella SA, Cabinian MA, Crim MT, Sullivan S, Heiges M, Craven SH, Rosenberg CS, Collins MH, et al. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2006, 2:e77. 10.1371/journal.ppat.0020077, 1526708, 16879036.
49. Jung C, Lee CY, Grigg ME. The SRS superfamily of Toxoplasma surface proteins. Int J Parasitol 2004, 34:285-296. 10.1016/j.ijpara.2003.12.004, 15003490.
50. Lamb EW, Walls CD, Pesce JT, Riner DK, Maynard SK, Crow ET, Wynn TA, Schaefer BC, Davies SJ. Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development. PLoS Pathog 2010, 6:e1000892. 10.1371/journal.ppat.1000892, 2861709, 20442785.
51. Delcroix M, Medzihradsky K, Caffrey CR, Fetter RD, McKerrow JH. Proteomic analysis of adult S. mansoni gut contents. Mol Biochem Parasitol 2007, 154:95-97. 10.1016/j.molbiopara.2007.03.008, 2732360, 17451823.
52. Merckelbach A, Hasse S, Dell R, Eschlbeck A, Ruppel A. cDNA sequences of Schistosoma japonicum coding for two cathepsin B-like proteins and Sj32. Trop Med Parasitol 1994, 45:193-198.
53. Lichtenbergova L, Kolbekova P, Kourilova P, Kasny M, Mikes L, Haas H, Schramm G, Horak P, Kolarova L, Mountford AP. Antibody responses induced by Trichobilharzia regenti antigens in murine and human hosts exhibiting cercarial dermatitis. Parasite Immunol 2008, 30:585-595. 2680328, 19067839.
54. Leptak CL, McKerrow JH. Schistosome egg granulomas and hepatic expression of TNF-alpha are dependent on immune priming during parasite maturation. J Immunol 1997, 158:301-307.
55. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991, 21:2679-2686. 10.1002/eji.1830211106, 1936116.
56. Ganley-Leal LM, Mwinzi PN, Cetre-Sossah CB, Andove J, Hightower AW, Karanja DM, Colley DG, Secor WE. Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans. Infect Immun 2006, 74:2169-2176. 10.1128/IAI.74.4.2169-2176.2006, 1418888, 16552047.
57. Nyindo M, Kariuki TM, Mola PW, Farah IO, Elson L, Blanton RE, King CL. Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons. Infect Immun 1999, 67:636-642. 96366, 9916070.
58. Correa-Oliveira R, Caldas IR, Gazzinelli G. Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol Today 2000, 16:397-399. 10.1016/S0169-4758(00)01740-3, 10951600.
59. Wynn TA, Hoffmann KF. Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2?. Parasitol Today 2000, 16:497-501. 10.1016/S0169-4758(00)01788-9, 11063861.
60. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE. Helminth parasites--masters of regulation. Immunol Rev 2004, 201:89-116. 10.1111/j.0105-2896.2004.00191.x, 15361235.
61. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, Duke M, Don TA, McManus DP, Correa-Oliveira R, Loukas A. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 2006, 12:835-840. 10.1038/nm1430, 16783371.
62. Jankovic D, Aslund L, Oswald IP, Caspar P, Champion C, Pearce E, Coligan JE, Strand M, Sher A, James SL. Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. J Immunol 1996, 157:806-814.
63. Sajid M, McKerrow JH, Hansell E, Mathieu MA, Lucas KD, Hsieh I, Greenbaum D, Bogyo M, Salter JP, Lim KC, et al. Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. Mol Biochem Parasitol 2003, 131:65-75. 10.1016/S0166-6851(03)00194-4, 12967713.